Implications of Failure to Routinely Diagnose Resistance to Second-Line Drugs in Patients With Rifampicin-Resistant Tuberculosis on Xpert MTB/RIF: A Multisite Observational Study

BACKGROUND. Xpert MTB/RIF (Xpert) detects rifampicin-resistant tuberculosis (RR-tuberculosis), enabling physicians to rapidly initiate a World Health Organization–recommended 5-drug regimen while awaiting second-line drug-susceptibility test (DST) results. We quantified the second-line DST results t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Jacobson, Karen R., Barnard, Marinus, Kleinman, Mary B., Streicher, Elizabeth M., Ragan, Elizabeth J., White, Laura F., Shapira, Ofer, Dolby, Tania, Simpson, John, Scott, Lesley, Stevens, Wendy, van Helden, Paul D., Van Rie, Annelies, Warren, Robin M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434334/
https://ncbi.nlm.nih.gov/pubmed/28199520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados